Results GLP-1RA reduced major cardiovascular events (MACE) by 14% (HR = 0.86, 95% CI 0.790.94, P = 0.006) with a non-significant heterogeneity between subgroups of patients with and without cardiovascular disease (P = 0.127)
PlexusDx recommends taking your weekly dose fasted, then waiting 30 minutes before eating a full meal
Similarly, if you develop recurrent reactions at multiple sites or notice skin changes such as lumps, depressions, or thickening, contact your healthcare provider for evaluation
Most side effects reported in clinical trials have been mild to moderate and may improve as the body adjusts during dose escalation
You may also experience increased fatigue, mild vomiting, or constipation if your body is processing a higher effective dose than it was calibrated for